Vaxcyte Inc
PCVXNASDAQStock · Data from SEC EDGAR 13F · Held by 4 of 87 tracked investors
Vaxcyte Inc at a glance
An overview of the financial statements, in plain language. Switch to the advanced view for charts.
- Valuation15
- Growth–
- Profitability25
- Quality15
- Debt100
- Stability20
- ✓It has more cash than debt.
- ✓The analysts' average target is 93% above the price.
- !The company is loss-making: net profit is negative.
The score describes the quality and the past of the company based on its statements (the FinBoss model, indicative). A high score is not a buy signal and a low one is not a sell signal. Data source: Yahoo Finance, prices and statements in USD.
Is the stock expensive?
ExpensiveThe company has no earnings, so the P/E cannot be calculated.
- P/E
- –
- P/S
- –
- EV/EBITDA
- -6.6×
Is the company growing?
–Too few years to compare. Last year –.
Does it make money?
Loss-makingNet margin: 0.0%.
Is it financially healthy?
Yes- Cash
Earnings results
| Quarter | Reported | EPS | Analyst estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | 5 Aug 2026 | -1.97 | -1.47 | -34% |
| Mar 2026 | 6 May 2026 | -2.30 | -1.86 | -23.7% |
| Dec 2025 | 24 Feb 2026 | -1.80 | -1.46 | -23.3% |
| Sep 2025 | 4 Nov 2025 | -1.56 | -1.27 | -22.8% |
EPS is earnings per share. The surprise is the difference against the analysts' consensus. Source: Nasdaq, in dollars.
Chart PCVX
Insider purchases
last 90 days, SEC Form 4Which investors hold this stock
4LA Lee Ainslie Maverick Capital | 0.83% |
RD Ray Dalio Bridgewater Associates | 0.01% |
Ns Norský státní fond Norges Bank | 0.01% |
Šn Švýcarská národní banka Swiss National Bank | 0.01% |
Frequently asked questions
How much is Vaxcyte Inc (PCVX) stock?
Vaxcyte Inc shares trade at $60.67, +1.17% over the last trading day. The price is delayed.
What is the market cap of Vaxcyte Inc?
The market cap of Vaxcyte Inc is about $9.5B.
Which big investors hold Vaxcyte Inc?
According to the latest 13F filings, 4 of 87 tracked investors hold Vaxcyte Inc, for example Lee Ainslie, Ray Dalio, Norský státní fond.
When will Vaxcyte Inc report its next results?
The next earnings report of Vaxcyte Inc is expected on 3 Nov 2026.
Source: SEC EDGAR 13F-HR (quarterly filings). The data is indicative and is not investment advice.